发明名称 |
RECOMBINANT MODIFIED VACCINIA VIRUS ANKARA INFLUENZA VACCINE |
摘要 |
The invention concerns a recombinant modified vaccinia virus Ankara (MVA virus) expressing at least two external influenza virus antigens and/or an epitope of one or more of the at least two antigens and at least two internal influenza virus antigens and/or an epitope of the at least two antigens. The invention, thus, concerns a recombinant MVA virus encoding multiple external and/or internal influenza virus antigens, preferably from multiple influenza virus strains. The invention further concerns the use of said recombinant MVA in preparing a medicament and vaccine for influenza virus. Further encompassed by the present invention are methods, composition and kits. |
申请公布号 |
WO2012048817(A2) |
申请公布日期 |
2012.04.19 |
申请号 |
WO2011EP04996 |
申请日期 |
2011.10.07 |
申请人 |
BAVARIAN NORDIC A/S;WEIGL, JOSEF;STEIGERWALD, ROBIN;HAUSMANN, JUERGEN |
发明人 |
WEIGL, JOSEF;STEIGERWALD, ROBIN;HAUSMANN, JUERGEN |
分类号 |
A61K39/145 |
主分类号 |
A61K39/145 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|